Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliviero Riggio

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
Hepatology (Baltimore, Md.)|January 30, 2018
Prediction of hepatic encephalopathy: Why disregard well-known risk factors?Lorenzo Ridola, Oliviero Riggio
Journal of Hepatology|September 23, 2022
Ammonia and prognosis of cirrhosis: A new perspective for identifying high-risk patientsLorenzo Ridola, Oliviero Riggio
Metabolic Brain Disease|December 5, 2008
Dietary and nutritional indications in hepatic encephalopathyManuela Merli, Oliviero Riggio
Journal of Hepatology|August 22, 2025
Rifaximin and Survival in Cirrhosis: An Unmet Clinical PromiseLorenzo Ridola, Oliviero Riggio
World Journal of Gastroenterology|August 25, 2009
Ascitic fluid analysis for diagnosis and monitoring of spontaneous bacterial peritonitisOliviero Riggio, Stefania Angeloni
Expert Opinion on Emerging Drugs|June 26, 2009
Emerging drugs for hepatic encephalopathyOliviero Riggio, Lorenzo Ridola
Journal of Hepatology|October 5, 2014
Correction of hyponatraemia in cirrhosis: treating more than a number!Andrés Cárdenas, Oliviero Riggio
Journal of Hepatology|December 3, 2014
Interaction between infection and hepatic encephalopathyManuela Merli, Oliviero Riggio
Journal of Hepatology|July 3, 2023
Comment on "TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis"Lorenzo Ridola, Oliviero Riggio
Alimentary Pharmacology & Therapeutics|March 4, 2022
Editorial: infections and hepatic encephalopathy-does the chicken or the egg come FIRST? A novel perspective at the horizonOliviero Riggio, Lorenzo Ridola
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
Hepatology (Baltimore, Md.)|January 30, 2018
Prediction of hepatic encephalopathy: Why disregard well-known risk factors?Lorenzo Ridola, Oliviero Riggio
Journal of Hepatology|September 23, 2022
Ammonia and prognosis of cirrhosis: A new perspective for identifying high-risk patientsLorenzo Ridola, Oliviero Riggio
Metabolic Brain Disease|December 5, 2008
Dietary and nutritional indications in hepatic encephalopathyManuela Merli, Oliviero Riggio
Journal of Hepatology|August 22, 2025
Rifaximin and Survival in Cirrhosis: An Unmet Clinical PromiseLorenzo Ridola, Oliviero Riggio
World Journal of Gastroenterology|August 25, 2009
Ascitic fluid analysis for diagnosis and monitoring of spontaneous bacterial peritonitisOliviero Riggio, Stefania Angeloni
Expert Opinion on Emerging Drugs|June 26, 2009
Emerging drugs for hepatic encephalopathyOliviero Riggio, Lorenzo Ridola
Journal of Hepatology|October 5, 2014
Correction of hyponatraemia in cirrhosis: treating more than a number!Andrés Cárdenas, Oliviero Riggio
Journal of Hepatology|December 3, 2014
Interaction between infection and hepatic encephalopathyManuela Merli, Oliviero Riggio
Journal of Hepatology|July 3, 2023
Comment on "TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis"Lorenzo Ridola, Oliviero Riggio
Alimentary Pharmacology & Therapeutics|March 4, 2022
Editorial: infections and hepatic encephalopathy-does the chicken or the egg come FIRST? A novel perspective at the horizonOliviero Riggio, Lorenzo Ridola
Pageof 17